Approximately six million doses are available, sufficient to vaccinate three million people, considering that the complete vaccination schedule consists of two doses.
Changing the strains used in the vaccines is crucial to the effectiveness of the dose, as the virus adapts and mutates, Anvisa stated.
A technical note published by Oxfam Brasil stresses the need to gear up for new disease outbreaks. “While China has more than a thousand factories producing IFA24, in Brazil this number comes near 15,” the document reads.
According to the health minister, the total planned stand at BRL 23 billion in private investment, plus funding from the National Bank for Economic and Social Development (BNDES) and the Financier of Studies and Projects (Finep), adding up to BRL 42.1 billion.
For 50 years, the country’s National Immunization Program (PNI) has been carrying out the ambitious mission of immunizing a huge population spread over a continent-sized territory deeply marked by the diversity of cultures and landscapes and contrasting living conditions.